Tonix Pharmaceuticals Holding (TNXP) Retained Earnings (2010 - 2026)
Tonix Pharmaceuticals Holding (TNXP) posted quarterly Retained Earnings of -$283000.0 for Q1 2026, down 6.39% year-over-year from -$302321.3 in Q1 2025, and up 99.97% quarter-over-quarter from -$854.7 million in Q4 2025.
Tonix Pharmaceuticals Holding (TNXP) Retained Earnings (2010 - 2026) Analysis & Trends
Tonix Pharmaceuticals Holding's Retained Earnings history runs 17 years deep, the most recent figure standing at -$283000.0 for Q1 2026.
- In Q1 2026, Retained Earnings fell 6.39% year-over-year to -$283000.0; the TTM figure through Mar 2026 stood at -$283000.0 (down 6.39% YoY), while the FY2025 annual figure was -$854.7 million, down 335082.35% from the prior year.
- Retained Earnings for Q1 2026 stood at -$283000.0, up from -$854.7 million in the prior quarter.
- The five-year high for Retained Earnings was -$118000.0 in Q1 2022, with the low at -$854.7 million in Q4 2025.
- The 5-year median for Retained Earnings is -$283000.0 (2026), against an average of -$283.5 million.
- The sharpest annual moves came in 2022 and 2024: Retained Earnings plunged 541082.72% in 2022, then surged 99.96% in 2024.
- Tonix Pharmaceuticals Holding's Retained Earnings stood at -$167000.0 in 2022, then sank by 359575.45% to -$600.7 million in 2023, then soared by 99.96% to -$255000.0 in 2024, then sank by 335082.35% to -$854.7 million in 2025, then surged by 99.97% to -$283000.0 in 2026.
- Business Quant data shows TNXP's Retained Earnings at -$283000.0 in Q1 2026, -$854.7 million in Q4 2025, and -$807.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -4.00 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 13.05 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -104.13 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 4.38 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -6.33 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 6.57 Bn |
| 10 | Tonix Pharmaceuticals Holding | 213.43 Mn | 213.43 Mn | 12.84 Mn | -935.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -935.46 Mn |
| Mar 31, 2026 | -283,000.00 |
| Dec 31, 2025 | -854.72 Mn |
| Sep 30, 2025 | -807.81 Mn |
| Jun 30, 2025 | -270,000.00 |
| Mar 31, 2025 | -266,000.00 |
| Dec 31, 2024 | -255,000.00 |
| Sep 30, 2024 | -250,000.00 |
| Jun 30, 2024 | -243,000.00 |
| Mar 31, 2024 | -615.60 Mn |
| Dec 31, 2023 | -600.66 Mn |
| Sep 30, 2023 | -573.34 Mn |
| Jun 30, 2023 | -212,000.00 |
| Mar 31, 2023 | -516.99 Mn |
| Dec 31, 2022 | -167,000.00 |
| Sep 30, 2022 | -438.36 Mn |
| Jun 30, 2022 | -409.38 Mn |
| Mar 31, 2022 | -118,000.00 |
| Dec 31, 2021 | -92,000.00 |
| Sep 30, 2021 | -81,000.00 |